99
Views
11
CrossRef citations to date
0
Altmetric
Drug Evaluations

Anti-IgE in allergic asthma and rhinitis: an update

, MRCP, , MRCPCH & , MD MRCP DM
Pages 1739-1747 | Published online: 26 Oct 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Daniel Colodenco, Oscar Palomares, Carlos Celis, Alan Kaplan & Christian Domingo. (2018) Moving toward consensus on diagnosis and management of severe asthma in adults. Current Medical Research and Opinion 34:3, pages 387-399.
Read now
K Suresh Babu, Riccardo Polosa & Jaymin B Morjaria. (2013) Anti-IgE – emerging opportunities for Omalizumab. Expert Opinion on Biological Therapy 13:5, pages 765-777.
Read now
Louis-Philippe Boulet & Marie-Ève Boulay. (2011) Asthma-related comorbidities. Expert Review of Respiratory Medicine 5:3, pages 377-393.
Read now
Jaymin B Morjaria & Riccardo Polosa. (2009) Off-label use of omalizumab in non-asthma conditions: new opportunities. Expert Review of Respiratory Medicine 3:3, pages 299-308.
Read now

Articles from other publishers (7)

M. Carlsson, L. Thorell, A. Sj?lander & S. Larsson-Faria. (2015) Variability of Total and Free IgE Levels and IgE Receptor Expression in Allergic Subjects in and Out of Pollen Season. Scandinavian Journal of Immunology 81:4, pages 240-248.
Crossref
Hoan Linh Banh, June Trevoy, Henry Pabst, Jeremy Beach & Dilini Vethanayagam. (2012) Persistent elevation of peripheral blood myeloid cell counts associated with omalizumab therapy. American Journal of Health-System Pharmacy 69:4, pages 302-306.
Crossref
Jaymin B. Morjaria & Jack A. Kastelik. (2011) Unusual asthma syndromes and their management. Therapeutic Advances in Chronic Disease 2:4, pages 249-264.
Crossref
. (2009) Current World Literature. Current Opinion in Allergy & Clinical Immunology 9:2, pages 177-184.
Crossref
. (2009) Current World Literature. Current Opinion in Pulmonary Medicine 15:1, pages 79-87.
Crossref
Christopher WT Miller, Narayanaswamy Krishnaswamy, Chambless Johnston & Guha Krishnaswamy. (2008) Severe asthma and the omalizumab option. Clinical and Molecular Allergy 6:1.
Crossref
. (2008) Current World Literature. Current Opinion in Allergy & Clinical Immunology 8:3, pages 276-285.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.